80 related articles for article (PubMed ID: 8563484)
1. Glucocorticoid-induced modulation of cytokine secretion from normal and leukemic human myelomonocytic cells.
Welker P; Lippert U; Nürnberg W; Krüger-Krasagakes S; Möller A; Czarnetzki BM
Int Arch Allergy Immunol; 1996 Feb; 109(2):110-5. PubMed ID: 8563484
[TBL] [Abstract][Full Text] [Related]
2. Modulation of in vitro cytokine release from human leukemic mast cells (HMC-1) by glucocorticoids.
Lippert U; Welker P; Krüger-Krasagakes S; Möller A; Henz BM
Skin Pharmacol; 1996; 9(2):93-8. PubMed ID: 8722602
[TBL] [Abstract][Full Text] [Related]
3. Constitutive protein expression of monocyte chemotactic protein-1 (MCP-1) by myelomonocytic cell lines and regulation of the secretion by anti- and proinflammatory stimuli.
Steube KG; Meyer C; Drexler HG
Leuk Res; 1999 Sep; 23(9):843-9. PubMed ID: 10475624
[TBL] [Abstract][Full Text] [Related]
4. Methyl-prednisolone up-regulates monocyte interleukin-10 production in stimulated whole blood.
Hodge S; Hodge G; Flower R; Han P
Scand J Immunol; 1999 May; 49(5):548-53. PubMed ID: 10320649
[TBL] [Abstract][Full Text] [Related]
5. Multiple regulation of constitutive and induced interleukin 8 secretion in human myelomonocytic cell lines.
Steube KG; Meyer C; Drexler HG
Cytokine; 2000 Aug; 12(8):1236-9. PubMed ID: 10930303
[TBL] [Abstract][Full Text] [Related]
6. CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia.
Watanabe J; Sato K; Osawa Y; Horiuchi T; Kato S; Hikota-Saga R; Maekawa T; Yamamura T; Kobayashi A; Kobayashi S; Kimura F
Int J Hematol; 2018 Jul; 108(1):47-57. PubMed ID: 29600428
[TBL] [Abstract][Full Text] [Related]
7. Different effects of various hematopoietic growth factors on myelomonocytic cell line (KY-821) and its drug-resistant sublines.
Fukuda T; Kakihara T; Kamishima T; Ohnishi Y; Naito M; Kishi K; Shibata A
Leuk Res; 1993 Apr; 17(4):325-32. PubMed ID: 8387619
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma and LPS overcome glucocorticoid inhibition of priming for superoxide release in human monocytes. Evidence that secretion of IL-1 and tumor necrosis factor-alpha is not essential for monocyte priming.
Szefler SJ; Norton CE; Ball B; Gross JM; Aida Y; Pabst MJ
J Immunol; 1989 Jun; 142(11):3985-92. PubMed ID: 2541203
[TBL] [Abstract][Full Text] [Related]
9. Differential cytokine profiles upon comparing selective versus classic glucocorticoid receptor modulation in human peripheral blood mononuclear cells and inferior turbinate tissue.
Beck IM; Van Crombruggen K; Holtappels G; Daubeuf F; Frossard N; Bachert C; De Bosscher K
PLoS One; 2015; 10(4):e0123068. PubMed ID: 25875480
[TBL] [Abstract][Full Text] [Related]
10. Enhanced glucocorticoid sensitivity of cytokine release from circulating leukocytes stimulated with lipopolysaccharide in healthy male smokers.
Wirtz PH; von Känel R; Kunz-Ebrecht S; Ehlert U; Fischer JE
Brain Behav Immun; 2004 Nov; 18(6):536-43. PubMed ID: 15331124
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 production after pro-inflammatory stimulation of neutrophils and monocytic cells of the newborn. Comparison to exogenous interleukin-10 and dexamethasone levels needed to inhibit chemokine release.
Davidson D; Miskolci V; Clark DC; Dolmaian G; Vancurova I
Neonatology; 2007; 92(2):127-33. PubMed ID: 17389814
[TBL] [Abstract][Full Text] [Related]
12. The effect of TNF-alpha, PMA, and LPS on plasma and cell-associated IL-8 in human leukocytes.
Lund T; Østerud B
Thromb Res; 2004; 113(1):75-83. PubMed ID: 15081568
[TBL] [Abstract][Full Text] [Related]
13. Dexamethasone antagonizes IL-4 and IL-10-induced release of IL-1RA by monocytes but augments IL-4-, IL-10-, and TGF-beta-induced suppression of TNF-alpha release.
Joyce DA; Steer JH; Kloda A
J Interferon Cytokine Res; 1996 Jul; 16(7):511-7. PubMed ID: 8836916
[TBL] [Abstract][Full Text] [Related]
14. Relative cytokine-stimulating activities of surface components of the oral periodontopathogenic bacterium Actinobacillus actinomycetemcomitans.
Reddi K; Wilson M; Poole S; Meghji S; Henderson B
Cytokine; 1995 Aug; 7(6):534-41. PubMed ID: 8580369
[TBL] [Abstract][Full Text] [Related]
15. Concentration-dependent roles for heparin in modifying lipopolysaccharide-induced activation of mononuclear cells in whole blood.
Hochart H; Jenkins PV; Preston RJ; Smith OP; White B; O'Donnell J
Thromb Haemost; 2008 Mar; 99(3):570-5. PubMed ID: 18327406
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factor-alpha by Mycobacterium tuberculosis components.
Zhang Y; Doerfler M; Lee TC; Guillemin B; Rom WN
J Clin Invest; 1993 May; 91(5):2076-83. PubMed ID: 7683696
[TBL] [Abstract][Full Text] [Related]
17. Interleukin (IL)-10, but not IL-4 or IL-13, inhibits cytokine production and growth in juvenile myelomonocytic leukemia cells.
Iversen PO; Hart PH; Bonder CS; Lopez AF
Cancer Res; 1997 Feb; 57(3):476-80. PubMed ID: 9012477
[TBL] [Abstract][Full Text] [Related]
18. Tetrandrine potentiates the glucocorticoid pharmacodynamics via inhibiting P-glycoprotein and mitogen-activated protein kinase in mitogen-activated human peripheral blood mononuclear cells.
Xu W; Meng K; Tu Y; Tanaka S; Onda K; Sugiyama K; Hirano T; Yamada H
Eur J Pharmacol; 2017 Jul; 807():102-108. PubMed ID: 28408143
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids inhibit placental cytokines from cultured normal and preeclamptic placental explants.
Xu B; Makris A; Thornton C; Hennessy A
Placenta; 2005; 26(8-9):654-60. PubMed ID: 16085044
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-4 in chronic myelomonocytic leukemia. Growth suppression of hematopoietic precursors in the chronic phase and stimulation in the acute phase.
Yanagisawa K; Kishimoto K; Horiuchi T; Takada K; Yasukawa M; Fujita S
Acta Haematol; 1994; 92(2):104-8. PubMed ID: 7817702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
